医師アドバイザリーサービスの市場規模、シェア、動向分析レポート：サービス別、最終用途別、地域別、セグメント予測、2024年～2030年

医師アドバイザリーサービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の医師アドバイザリーサービス市場規模は2030年までに66億7,000万米ドルに達し、2024～2030年のCAGRは6.8％を記録すると予測されています。

同市場は、個別化医療の需要の高まり、デジタル技術の統合、患者中心のケアへの注目の高まり、価値ベースのケアモデルの出現など、いくつかの重要な要因によって牽引されています。

医師のアドバイザリーサービスにデジタル技術を統合することが、市場の成長を大きく後押ししています。これらの技術は、アドバイザリーサービスの有効性、効率性、アクセシビリティを高め、患者の転帰改善と医療プロセスの合理化につながります。人工知能（AI）とデータ解析は、深い洞察と予測能力を提供するため、医師アドバイザリーサービスにおいて極めて重要です。AIアルゴリズムは、大規模なデータセットを分析してパターンを特定し、患者の転帰を予測し、個別化された治療計画を推奨することができます。この技術は、医師がより多くの情報に基づいた意思決定を行うことをサポートし、それによって治療の質を向上させ、ミスのリスクを低減します。

さらに、主要企業は技術革新を推進し、サービス提供を拡大し、市場での地位を強化しています。これらの企業は、技術を活用し、新たなビジネスモデルを模索することで、サービス提供を強化し、医療プロバイダーの進化するニーズに対応しています。例えば、PremierはAIと機械学習を活用して、医師のアドバイザリーサービスを強化しています。同社は、医師がリスクの高い患者を特定し、それに応じてケアプランを調整するのに役立つ予測分析ツールを導入しています。さらに、これらの企業は市場での足跡を拡大するために買収や提携に注力しています。例えば、2022年12月、AppriseMDはUnityPoint Healthと提携し、アイオワ州、イリノイ州、ウィスコンシン州の全20の地域病院に利用管理医師アドバイザーサービスを提供しています。

医師アドバイザリーサービス市場のレポートハイライト

• サービス別では、医師アドバイザーへの即時アクセス、臨床スタッフと経営陣の連携強化、複雑な症例の効率的な解決といった利点から、オンサイト型が60.69%のシェアを占め、2023年の市場を独占しました。
• 2023年の市場シェアは、医療プロバイダーが49.71％で最大。医療プロバイダーは、複雑な規制への対応、ケアの質と治療成績の向上、償還プロセスの最適化、患者ケアの改善などを目的に、医師アドバイザリーサービスの採用を増やしています。
• 北米は2023年の売上高シェア52.50%で世界市場を独占しています。規制による圧力、価値観による医療へのシフト、医療機関内の業務効率改善の必要性などが相まって成長を牽引しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医師アドバイザリーサービス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 医師アドバイザリーサービス市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響
  • ケーススタディ

第4章 医師アドバイザリーサービス市場：サービス別、推定・動向分析

• サービス市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界の医師アドバイザリーサービス市場：サービス別
• オンサイト
• リモート

第5章 医師アドバイザリーサービス市場：最終用途別、推定・動向分析

• 最終用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界の医師アドバイザリーサービス市場：最終用途別
• 医療支払者
• 医療プロバイダー
• その他

第6章 医師アドバイザリーサービス市場：地域別、サービス別、最終用途別推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2023年
• 企業プロファイル
  • R1
  • Remedi Health Solutions
  • Physician Advisory Solutions
  • MedsRole
  • Sound Physician
  • Xsolis
  • AppriseMD
  • DCCS Consulting
  • CorroHealth, Inc.
  • Precision Healthcare Consultant
  • MedMetrix
  • EdiPhy Advisors
  • Optum

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Physician Advisory Services Market, by region, 2018 - 2030 (USD Million)
• Table 3 North America Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 4 North America Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 5 U.S. Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 6 U.S. Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 Canada Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 8 Canada Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 9 Mexico Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 10 Mexico Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 11 Europe Physician Advisory Services Market, by region, 2018 - 2030 (USD Million)
• Table 12 Europe Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 13 Europe Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 14 Germany Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 15 Germany Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 16 UK Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 17 UK Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 18 France Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 19 France Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 20 Italy Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 21 Italy Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 22 Spain Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 23 Spain Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 24 Denmark Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 25 Denmark Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 26 Sweden Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 27 Sweden Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 28 Norway Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 29 Norway Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 Asia Pacific Physician Advisory Services Market, by region, 2018 - 2030 (USD Million)
• Table 31 Asia Pacific Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 32 Asia Pacific Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 33 China Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 34 China Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Japan Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 36 Japan Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 37 India Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 38 India Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 39 South Korea Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 40 South Korea Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Australia Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 42 Australia Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 43 Thailand Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 44 Thailand Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 45 Latin America Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 46 Latin America Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 47 Brazil Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 48 Brazil Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 49 Argentina Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 50 Argentina Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 51 MEA Physician Advisory Services Market, by region, 2018 - 2030 (USD Million)
• Table 52 MEA Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 53 MEA Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 South Africa Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 55 South Africa Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 56 Saudi Arabia Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 57 Saudi Arabia Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 58 UAE Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 59 UAE Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 60 Kuwait Physician Advisory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 61 Kuwait Physician Advisory Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Physician advisory services market: market outlook
• Fig. 9 Physician advisory services market competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Physician advisory services Market driver impact
• Fig. 13 Physician advisory services Market restraint impact
• Fig. 14 Physician advisory services Market strategic initiatives analysis
• Fig. 15 Physician advisory services Market: Service movement analysis
• Fig. 16 Physician advisory services Market: Service outlook and key takeaways
• Fig. 17 On-site market estimates and forecast, 2018 - 2030
• Fig. 18 Remote market estimates and forecast, 2018 - 2030
• Fig. 19 Physician advisory services Market: End Use movement analysis
• Fig. 20 Physician advisory services Market: End Use outlook and key takeaways
• Fig. 21 Healthcare Payers market estimates and forecast, 2018 - 2030
• Fig. 22 Healthcare providers market estimates and forecast, 2018 - 2030
• Fig. 23 Others market estimates and forecast, 2018 - 2030
• Fig. 24 Global Physician advisory services Market: Regional movement analysis
• Fig. 25 Global Physician advisory services Market: Regional outlook and key takeaways
• Fig. 26 Global Physician advisory services Market share and leading players
• Fig. 27 North America market share and leading players
• Fig. 28 Europe market share and leading players
• Fig. 29 Asia Pacific market share and leading players
• Fig. 30 Latin America market share and leading players
• Fig. 31 Middle East & Africa market share and leading players
• Fig. 32 North America: SWOT
• Fig. 33 Europe SWOT
• Fig. 34 Asia Pacific SWOT
• Fig. 35 Latin America SWOT
• Fig. 36 MEA SWOT
• Fig. 37 North America, by country
• Fig. 38 North America market estimates and forecasts, 2018 - 2030
• Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 40 Canada market estimates and forecasts, 2018 - 2030
• Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 42 Europe market estimates and forecasts, 2018 - 2030
• Fig. 43 UK market estimates and forecasts, 2018 - 2030
• Fig. 44 Germany market estimates and forecasts, 2018 - 2030
• Fig. 45 France market estimates and forecasts, 2018 - 2030
• Fig. 46 Italy market estimates and forecasts, 2018 - 2030
• Fig. 47 Spain market estimates and forecasts, 2018 - 2030
• Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 49 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 50 Norway market estimates and forecasts, 2018 - 2030
• Fig. 51 Asia Pacific
• Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 53 China market estimates and forecasts, 2018 - 2030
• Fig. 54 Japan market estimates and forecasts, 2018 - 2030
• Fig. 55 India market estimates and forecasts, 2018 - 2030
• Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 57 Australia market estimates and forecasts, 2018 - 2030
• Fig. 58 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 61 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 62 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 65 UAE market estimates and forecasts, 2018 - 2030
• Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 67 Market share of key market players- Physician Advisory Services Market

Physician Advisory Services Market Growth & Trends:

The global physician advisory services market size is expected to reach USD 6.67 billion by 2030, registering a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors, including the rising demand for personalized healthcare, integration of digital technologies, increasing focus on patient-centered care, and the emergence of value-based care models.

Integrating digital technologies into physician advisory services is significantly driving market growth. These technologies enhance the effectiveness, efficiency, and accessibility of advisory services, leading to better patient outcomes and streamlined healthcare processes. Artificial Intelligence (AI) and data analytics are pivotal in physician advisory services as they provide deep insights and predictive capabilities. AI algorithms can analyze large datasets to identify patterns, predict patient outcomes, and recommend personalized treatment plans. This technology supports physicians in making more informed decisions, thereby improving the quality of care and reducing the risk of errors.

Furthermore, key players drive innovation, expand their service offerings, and strengthen their market positions. These companies are leveraging technology and exploring new business models to enhance their service delivery and address the evolving needs of healthcare providers. For instance, Premier is leveraging AI and machine learning to enhance its physician advisory services. The company has introduced predictive analytics tools that help physicians identify high-risk patients and tailor care plans accordingly. Moreover, these companies are focusing on acquisitions and partnerships to expand their footprints in the market. For instance, in December 2022, AppriseMD partnered with UnityPoint Health to deliver utilization management physician advisor services to all 20 regional hospitals across Iowa, Illinois, and Wisconsin.

Physician Advisory Services Market Report Highlights:

• Based on service type, the on-site segment dominated the market in 2023 with a share of 60.69%, owing to the advantage of immediate access to physician advisors, facilitating better coordination between clinical staff and management, and enabling more efficient resolution of complex cases
• Healthcare providers held the largest market share of 49.71% in 2023. Healthcare providers are increasingly adopting physician advisory services to navigate complex regulations, improve care quality and outcome, optimize the reimbursement process, and improve patient care
• North America dominated the global market with a revenue share of 52.50% in 2023. A combination of regulatory pressures drives the growth, the shift towards value-based care, and the need for improved operational efficiency within healthcare organizations

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Service
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Physician Advisory Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Physician Advisory Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. COVID-19 Impact
  • 3.3.4. Case Study

Chapter 4. Physician Advisory Services Market: Service Estimates & Trend Analysis

• 4.1. Servic Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Physician Advisory Services Market by Service Outlook
• 4.4. On-site
  • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Billion)
• 4.5. Remote
  • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Billion)

Chapter 5. Physician Advisory Services Market: End Use Estimates & Trend Analysis

• 5.1. End Use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Physician Advisory Services Market by End Use Outlook
• 5.4. Healthcare Payers
  • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Billion)
• 5.5. Healthcare Providers
  • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Billion)
• 5.6. Others
  • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Billion)

Chapter 6. Physician Advisory Services Market: Regional Estimates & Trend Analysis, By Service, and By End Use

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ reimbursement structure
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework/ reimbursement structure
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework/ reimbursement structure
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ reimbursement structure
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ reimbursement structure
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ reimbursement structure
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key Company Market Share Analysis, 2023
• 7.4. Company Profiles
  • 7.4.1. R1
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Remedi Health Solutions
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Physician Advisory Solutions
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. MedsRole
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Sound Physician
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Xsolis
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. AppriseMD
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. DCCS Consulting
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. CorroHealth, Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Precision Healthcare Consultant
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. MedMetrix
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. EdiPhy Advisors
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Optum
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives